Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMPO-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZRANB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SRSF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS2L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPESP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM189-UBE2V1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MPHOSPH9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEPDC1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FSD1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35F6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CWF19L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLGAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on